J.D. Durkin joins us live from D.C. with the latest on the looming government shutdown, and President Trump's efforts to take credit for advances in the aviation industry.
Taylor Swift is getting a bad reputation with her fans.
The star is catching flack for markups and gimmicks used in marketing her upcoming world tour. Not a single of swift's 33 North American dates have sold out since going on sale on December 13th. Fans blame Ticketmaster's Verified Fans program for their frustration. The program required fans to pre-register, and gave ticket-buyers the chance to improve their spot in line by buying merchandise.
Snapchat may soon follow YouTube's ad strategy after the company's ad sales team found that users often skip an ad within the first one second of its stream. The social media platform may start implementing a mandatory three-seconds of commercial space before users can 'skip' ahead of content.
The Biden administration says it will impose inflation penalties on dozens of drug makers to lower costs for those on Medicare.
Two of the top low-cost online retailers are going head to head in a new legal battle. Cheddar News' Michelle Castillo breaks the lawsuit down.
The number of Americans filing for jobless benefits fell last week as the labor market continues to thrive despite high interest rates and elevated costs.
The earliest version of Disney's Mickey Mouse will become public domain on Jan. 1, 2024.
The toy magic oven called the Cookeez Makery is one of the hottest toys for kids this holiday season.
In the UK, IKEA is looking to give away some meatballs, and not just regular-size meatballs.
Dwayne 'The Rock' Johnson is set to star in a movie playing MMA and UFC legend, Mark Care, while Kevin Hart will headline a boxing project over on Peacock.
Coca-Cola is recalling drinks sold in three southern states due to possible "foreign materials" inside cans.
Stocks jumped after the Dow Jones closed at a record high while fresh retail sales data showed positive consumer spending ahead of the holidays.
The Food and Drug Administration is asking Congress for new powers, including the ability to mandate drug recalls and require eyedrop makers to undergo inspections before shipping products to the U.S.
